Behind the science
Mapping disease at the cellular level: A single-cell revolution in drug discovery
A pioneering collaboration is unlocking the secrets of disease by zooming in on individual cells. Using single-cell and spatial genomics, scientists are discovering new cell types, revealing new drug targets, and harnessing artificial intelligence to transform how we understand and treat complex conditions – from COPD to liver and kidney disease.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Behind the science
Discover how we're getting ahead
Life at GSK
Find out what it's like to work with us
Make a difference with us
Do your best work with us
Be yourself with us
